Gertner Michael
Department of Surgery, Stanford University School of Medicine, Stanford, California 94305, USA.
Semin Pediatr Surg. 2006 Nov;15(4):302-8. doi: 10.1053/j.sempedsurg.2006.07.010.
The innovation process is often more important than the original idea, particularly when the ultimate goal is to improve patient care through technologically advanced products. Many physicians have great ideas; unfortunately, many of these great ideas are never translated to patient care improvements because of a misunderstanding of "the next step." In many cases, the next step is a step backward to understand the real clinical problem: "the clinical need." With the clinical need in hand, the most efficient path to a product for improved patient care can then be derived. Often, the most efficient pathway involves an appreciation of many issues, including intellectual property, regulatory pathways, finance, and clinical trial strategies. The integration of these issues underlies innovation in biomedical technology.